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The ER is an important intracellular organelle 
that carries out multiple physiological func­
tions such as protein folding, posttranslational 
modifications, biosynthesis of fatty acids and 
sterols, detoxification of xenobiotics, and the 
storage of intracellular calcium. Hepatocytes in 
the liver contain abundant ER, which endows 
the liver with the capacity to engage in lipid 
and drug metabolism as well as the production 
of plasma proteins.
The unfolded protein response (UPR) is 
a  signaling  system  that  is  activated  when 
cells are exposed to agents that perturb ER 
protein folding homeostasis (Kaufman, 1999; 
Ron and Walter, 2007). IRE1 is an ER trans­
membrane protein that plays a major role in 
the initiation of the UPR both in mammals 
and lower eukaryotes (Cox et al., 1993; Mori   
et al., 1993; Wang et al., 1998; Ron and Walter, 
2007). IRE1 activates the downstream tran­
scription factor XBP1 by inducing an uncon­
ventional splicing of XBP1 mRNA, thereby 
generating  a  potent  transcriptional  transac­
tivator, XBP1s (Yoshida et al., 2001; Calfon   
et  al.,  2002;  Lee  et  al.,  2002).  In  addition  to 
IRE1, two other ER transmembrane proteins, 
PERK and ATF6, also constitute UPR sig­
naling pathways in mammals (Kaufman, 1999; 
Ron and Walter, 2007). These three UPR sig­
naling branches are simultaneously activated 
when cells are treated with chemicals that inhibit 
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The mammalian stress sensor IRE1 plays a central role in the unfolded protein, or endoplasmic 
reticulum (ER), stress response by activating its downstream transcription factor XBP1 via 
an unconventional splicing mechanism. IRE1 can also induce the degradation of a subset 
of mRNAs in a process termed regulated IRE1-dependent decay (RIDD). Although diverse 
mRNA species can be degraded by IRE1 in vitro, the pathophysiological functions of RIDD 
are only beginning to be explored. Acetaminophen (APAP) overdose is the most frequent 
cause of acute liver failure in young adults in the United States and is primarily caused by 
CYP1A2-, CYP2E1-, and CYP3A4-driven conversion of APAP into hepatotoxic metabolites. 
We demonstrate here that genetic ablation of XBP1 results in constitutive IRE1 activation 
in the liver, leading to RIDD of Cyp1a2 and Cyp2e1 mRNAs, reduced JNK activation, and pro-
tection of mice from APAP-induced hepatotoxicity. A pharmacological ER stress inducer that 
activated IRE1 suppressed the expression of Cyp1a2 and Cyp2e1 in WT, but not IRE1-
deficient mouse liver, indicating the essential role of IRE1 in the down-regulation of these 
mRNAs upon ER stress. Our study reveals an unexpected function of RIDD in drug metabolism.
© 2012 Hur et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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by glutathione (GSH) conjugation (Mitchell et al., 1973b). 
However, excessive amounts of NAPQI deplete cellular 
GSH stores and covalently bind to macromolecules, resulting in   
cytotoxicity (Cohen and Khairallah, 1997). In addition, recent 
studies identified c­jun N­terminal kinase (JNK) as a central 
mediator of APAP hepatotoxicity (Gunawan et al., 2006; 
Henderson et al., 2007). It has been shown that NAPQI 
induces oxidative stress, which then activates JNK to induce 
cell death (Hanawa et al., 2008; Nakagawa et al., 2008).
In this study, we demonstrate that XBP1­deficient mice 
are protected from APAP hepatotoxicity. Ablation of XBP1 
in the liver suppressed the expression of Cyp1a2 and Cyp2e1, 
which is critical for the conversion of APAP to the toxic 
NAPQI in rodents. We demonstrate that IRE1 is hyper­
activated in XBP1­deficient mouse liver and cleaves Cyp1a2 
and Cyp2e1mRNAs, leading to their degradation. Our study 
reveals a novel function of the IRE1–XBP1 signaling path­
way in drug metabolism in the liver.
RESULTS
XBP1 deficiency in the liver protects mice  
from APAP-induced hepatotoxicity
To investigate the function of the UPR regulated by IRE1 
and XBP1 in APAP metabolism and hepatotoxicity, we used 
mice in which Xbp1 is inducibly deleted in the liver by polyin­
osinic:polycytidylic acid (poly[I:C]) treatment (Lee et al., 2008).   
Xbp1f/f;Mxcre (Xbp1) and the littermate control Xbp1f/f (WT) 
mice were injected with poly(I:C) and used for experiments 
after more than 3 wk of acclimation. A single dose of 500 mg 
APAP/kg markedly increased serum alanine aminotransferase 
(ALT) levels in WT mice, peaking at 24 h, and then decreasing 
to near basal levels on day 3, indicating APAP­induced acute 
liver injury (Fig. 1 A). In contrast, Xbp1 mice displayed only 
a modest induction of serum ALT levels by APAP treatment. 
APAP­induced mortality was also dramatically decreased in 
Xbp1 mice (Fig. 1 B). Histological analysis of the liver revealed 
markedly reduced liver injury in Xbp1 mice compared with 
WT animals that exhibited severe centrilobular necrosis and 
hemorrhage (Fig. 1 C), demonstrating that Xbp1 deficiency 
protected mice from APAP­induced hepatotoxicity.
Although the generation of toxic metabolites by hepato­
cytes is the primary mechanism of liver injury from APAP over­
dose, inflammatory responses mediated by the innate immune 
system also contribute to APAP hepatotoxicity (Blazka et al., 
1995; Liu et al., 2004; Liu and Kaplowitz, 2006). Xbp1f/f; 
Mxcre mice expressed cre recombinase both in the liver and 
the hematopoietic cells in the bone marrow of upon poly 
(I:C) injection (Martinon et al., 2010). We recently demon­
strated that XBP1 is required for optimal cytokine expression 
in  macrophages  and  controls  the  inflammatory  response 
(Martinon et al., 2010). To ascertain that XBP1 deficiency in 
hepatocytes and not in innate immune cells protected mice 
from APAP­induced hepatotoxicity, we crossed Xbp1f/f mice 
with Alb­cre mice expressing Cre recombinase under the 
control of the mouse albumin promoter to achieve hepatocyte­
specific deletion of XBP1 (Postic et al., 1999). Similar to Xbp1 
protein glycosylation or deplete ER calcium stores, such as 
tunicamycin or thapsigargin.
Analysis of mutant mice lacking key UPR regulators 
uncovered important physiological functions of the UPR (Lee 
and Glimcher, 2009; Rutkowski and Hegde, 2010). In normal 
cell physiology, the large amounts of proteins produced in 
specialized secretory cells can overwhelm ER capacity and 
disrupt cell homeostasis, leading to cell death, unless the ER 
stress  is  resolved  by  the  UPR  (Brewer  and  Hendershot, 
2005). Along this line, ablation of IRE1 or XBP1 caused 
severe abnormalities in exocrine pancreatic acinar cells, plasma 
B cells, zymogenic Paneth cells, and Chief cells in the gas­
trointestinal tract, manifested by failure of ER expansion, 
reduced production of secretory proteins, and increased apop­
tosis (Reimold et al., 2001; Lee et al., 2005; Zhang et al., 2005; 
Kaser et al., 2008; Huh et al., 2010; Iwawaki et al., 2010). These 
studies demonstrated a critical role for the IRE1/XBP1 
UPR branch in the expansion of the cellular secretory ma­
chinery required to handle large amounts of secretory proteins.
Liver is another highly synthetic organ that produces 
the  majority  of  plasma  proteins.  Surprisingly,  however, 
ablation of XBP1 or IRE1 in the adult liver did not sig­
nificantly decrease the plasma protein level (Lee et al., 2008; 
Zhang et al., 2011). Further, expression of protein secretory 
pathway genes was relatively normal in IRE1­ or XBP1­
deficient liver unless mice were treated with a pharmaco­
logic ER stressor, tunicamycin, which evokes a strong ER 
stress response (Lee et al., 2008; Zhang et al., 2011). Further, 
XBP1­ or IRE1­deficient hepatocytes did not exhibit 
any evidence of heightened ER stress, such as distended 
ER, reduced cell viability, or chaperone gene induction. Hence, 
the IRE1–XBP1 complex does not play a major role in the 
protein secretory function of the adult liver under normal 
conditions. In contrast, ablation of XBP1 in the liver drasti­
cally reduced plasma lipid levels, uncovering a novel function 
of the UPR regulated by IRE1–XBP1 in hepatic lipid 
metabolism (Lee et al., 2008).
We suspected, however, that this signaling pathway might 
have other key functions in liver, an organ responsible for 
the metabolism of most xenobiotics. The ER is an important 
organelle in drug metabolism, as most phase I enzymes includ­
ing cytochrome P450 oxidases and some phase II enzymes 
localize to the ER (Cribb et al., 2005). Acetaminophen (APAP) 
is a widely used analgesic drug. Although safe at therapeutic 
doses, overdose of APAP can cause severe liver damage 
characterized by centrilobular hepatic necrosis (Mitchell   
et al., 1973a). APAP hepatotoxicity is mainly mediated by 
N­acetyl­p­benzoquinone imine (NAPQI), which is gener­
ated by oxidation of APAP by P450 enzymes such as Cyp1a2, 
Cyp2e1, and Cyp3a4 (Raucy et al., 1989; Patten et al., 1993; 
Thummel et al., 1993; Zaher et al., 1998; James et al., 2003). 
Cyp2e1­null mice are markedly resistant (Lee et al., 1996), 
whereas Cyp1a2 and Cyp2e1 double­null mice are almost com­
pletely resistant to APAP­induced hepatotoxicity (Zaher et al., 
1998), indicating the essential role of these P450 enzymes in 
APAP induced liver damage. NAPQI is detoxified primarily JEM Vol. 209, No. 2 
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XBP1, but not in the control Xbp1f/f mice (Fig. 3 A). Western 
blotting and qRT­PCR demonstrated decreased expression 
of Cyp1a2 and Cyp2e1 in the liver of Xbp1LKO mice as well 
(Fig. 3, B and C). In contrast, genes involved in GSH synthesis, 
such as GSH synthetase, glutamate­cysteine ligase catalytic, and 
glutamate­cysteine ligase modifier subunits, were unaffected by 
XBP1 deficiency (Fig. 3 D). Nuclear factor erythroid­2–related 
factor 2 (Nrf2) which is considered a key regulator of the anti­
oxidant response (Chan and Kan, 1999; Chan et al., 2001), and 
its target genes such as GSH-S-transferase pi 1 (Gstpi) and UDP-
glucuronosyltransferase 1a6 (Ugt1a6), were also unchanged in   
Xbp1 liver (Fig. 3, D and E). Collectively, these data indicate 
that  XBP1  is  required  for  the  expression  of  Cyp1a2  and 
Cyp2e1, which are responsible for the generation of reactive 
NAPQI from APAP.
Effects of XBP1 ablation on APAP-induced GSH depletion 
and JNK activation
The reactive metabolite NAPQI generated from APAP by 
Cyp1a2 and Cyp2e1 P450 enzymes is normally removed by 
conjugation with GSH (James et al., 2003). Toxic doses of 
APAP deplete hepatic GSH, allowing covalent binding of 
NAPQI to intracellular macromolecules, which leads to cell 
death (Cohen and Khairallah, 1997). Hepatic GSH stores were 
rapidly decreased by APAP administration in both WT and 
Xbp1LKO mice, reaching background levels within 2 h, indicat­
ing that the reactive NAPQI overwhelmed the GSH­mediated 
mice that lacked XBP1 both in the liver and hematopoi­
etic cells, Xbp1f/f;Alb­cre (Xbp1LKO) mice were viable and 
grossly normal. Xbp1LKO mice were also resistant to APAP­
induced hepatotoxicity, as indicated by lower serum ALT levels 
and decreased necrosis compared with littermate controls 
(Fig. 2). These results indicate that XBP1 deficiency in liver 
parenchymal cells is sufficient to protect mice against APAP­ 
induced hepatotoxicity.
Decreased expression of Cyp1a2 and Cyp2e1  
in XBP1-deficient liver
To investigate the mechanism by which XBP1 regulates APAP 
metabolism, we measured mRNA levels of genes involved 
in drug metabolism using the RT2 Profiler PCR Array 
(SABiosciences). Notably, Cyp1a2 and Cyp2e1, which are 
crucial for APAP oxidation to the toxic NAPQI, were sig­
nificantly decreased in the liver of Xbp1 mice (Table S1). 
Cyp2e1 plays a major role in the conversion of APAP into 
hepatotoxic NAPQI (Gonzalez, 2007). Cyp1a2 also contributes 
to APAP metabolism and hepatotoxicity, although it has a 
lower APAP affinity than Cyp2e1 (Raucy et al., 1989; Patten 
et al., 1993). Quantitative RT­PCR (qRT­PCR) confirmed the   
decrease of hepatic Cyp1a2 and Cyp2e1 mRNA levels by 
poly(I:C) administration in Xbp1f/f;Mxcre mice that ablated 
Figure 1.  XBP1-deficient mice are resistant to APAP-induced liver 
toxicity. (A) Mice were i.p. injected with 500 mg/kg APAP after a 16-h fast. 
Serum ALT levels were measured at various time points. ALT measure-
ments were performed on animals only when they were alive. Each symbol 
represents one mouse. Horizontal lines represent mean values and SEM.  
(B) Survival of WT (n = 20) and Xbp1 mice (n = 16) after APAP administration. 
P < 0.02 (Mantel–Cox test). (C) H&E staining of liver sections. Mice were 
sacrificed 24 h after APAP injection. Dotted line indicates a necrotic area. Im-
ages are representative of at least five independent experiments. Bars, 0.5 mm.
Figure 2.  Protection of mice with liver-specific deletion of XBP1 
(Xbp1LKO) from APAP hepatotoxicity. (A) Mice were i.p. injected with 
500 mg/kg APAP after a 16-h fast. Bloods were drawn via tail vein at  
8 and 24 h after APAP injection for ALT measurements. *, P < 0.05. Hori-
zontal lines represent mean values and SEM. (B) H&E staining of liver 
sections. Mice were sacrificed 24 h after APAP injection. Images are  
representative of at least five independent experiments. Bar, 0.5 mm.310 IRE1 inhibits acute liver failure | Hur et al.
(Cederbaum et al., 2009), it is conceiv­
able that the reduction of Cyp2e1 in 
XBP1­deficient liver might ameliorate 
oxidative stress and JNK activation.
Inverse correlation between IRE1 activation  
and mRNA levels of Cyp1a2 and Cyp2e1
Because XBP1 is a transcriptional activator, we first sought to 
determine if XBP1 directly induced the transcription of Cyp1a2 
and Cyp2e1. Contrary to our prediction, adenoviral over­
expression of XBP1s failed to induce these P450 enzyme 
mRNAs in primary hepatocytes (Fig. 5 A). Furthermore, 
tunicamycin injection decreased hepatic Cyp1a2 and Cyp2e1 
mRNA levels, despite a strong induction of XBP1s and its 
target genes, BiP and ERdj4, arguing against a direct role   
of XBP1 in regulating these genes (Fig. 5, B and C).
Previously, we reported that the ablation of XBP1 led 
to feedback activation of its upstream enzyme IRE1 in 
the liver (Lee et al., 2008). IRE1 hyperactivation in XBP1­
deficient liver appeared to be an ER stress–independent 
event, given that ER morphology was normal and activa­
tion of other UPR branches was unaltered. Interestingly, 
recent studies have demonstrated that IRE1 can induce 
the degradation of certain mRNAs, a process known as 
regulated IRE1­dependent decay (RIDD; Han et al., 2009; 
Hollien et al., 2009; Oikawa et al., 2010). In contrast to   
the efficient relegation of XBP1 mRNA after cleavage by 
IRE1, in RIDD, mRNA substrates appear to be degraded 
after  the  cleavage,  presumably  by  cellular  ribonucleases 
(Lipson et al., 2008; Han et al., 2009; Hollien et al., 2009; 
Oikawa et al., 2010; Lee et al., 2011). These observations 
detoxification system of the liver (Fig. 4 A). Xbp1LKO mice ex­
hibited slightly faster recovery of GSH levels than WT mice, 
suggesting that the burden of toxic APAP metabolites was lower 
in the former (Fig. 4 A). In contrast, APAP­conjugated protein 
adducts were not substantially reduced in the XBP1­deficient 
liver, suggesting that the residual level of these P450 enzymes is 
sufficient to generate APAP adducts (Fig. 4, B and C).
JNK is activated by APAP­induced oxidative stress and 
plays a crucial role in the hepatotoxicity (Gunawan et al., 2006; 
Henderson et al., 2007; Kaplowitz et al., 2008; Nakagawa et al., 
2008). To determine the effect of XBP1 ablation on JNK 
activation, we measured the level of JNK phosphorylation 
in liver tissues by Western blotting after APAP treatment. In 
WT mice, JNK phosphorylation was strongly induced for 
6 h after APAP treatment, and then declined at the 24­h time 
point to low, but detectable levels, reflecting the prolonged 
oxidative stress (Fig. 4, B and C). Xbp1LKO mice also exhib­
ited marked induction of JNK phosphorylation at early time 
points (Fig. 4 B), consistent with GSH depletion and APAP 
adduct formation. Notably, JNK phosphorylation was decreased 
to baseline levels at the 24­h time point in Xbp1LKO mice, in 
contrast to the markedly higher levels in WT mice (Fig. 4 C), 
suggesting that the lack of prolonged JNK activation might 
contribute to the protection of XBP1­deficient mice from 
APAP­induced hepatotoxicity. Given that Cyp2e1 generates 
reactive oxygen species by metabolizing a variety of substrates 
Figure 3.  Decreased expression of 
Cyp1a2 and Cyp2e1 mRNAs in XBP1-
deficient liver accompanied by constitu-
tive activation of IRE1. (A) Total RNAs 
were isolated from the liver of Xbp1f/f;Mx1-cre 
and the control Xbp1f/f mice untreated (NT)  
or injected with poly (I:C) 3 wk before sacrifice. 
Cyp1a2 and Cyp2e1 mRNA levels were mea-
sured by qRT-PCR. n = 3–4 mice per group. 
(B) qRT-PCR analysis of the liver of Xbp1LKO 
and control Xbp1f/f mice. n = 3–5 mice per 
group. ***, P < 0.001. (C) Liver lysates were 
isolated from Xbp1f/f and Xbp1LKO mice and 
subjected to Western blot analysis. Phos-Tag 
gel electrophoresis was performed to better 
separate phosphorylated IRE1 from the  
unphosphorylated form. (D) qRT-PCR analysis 
of genes involved in antioxidant responses 
and drug metabolism regulated by Nrf2.  
n = 4 mice per group. (E) Nrf2 protein levels 
were determined by Western blot of liver 
nuclear extracts. Lysates from 293T cells 
transfected with Nrf2 plasmid or mock  
transfected served as control. Data are  
representative of at least three  
independent experiments.JEM Vol. 209, No. 2 
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Western blot analysis of liver lysates revealed that IRE1 
protein was induced and constitutively phosphorylated in 
the liver of Xbp1LKO mice, consistent with what has been 
observed in Xbp1 mice (Fig. 3 C). Phos­Tag SDS­PAGE 
analysis  demonstrated  that  IRE1  phosphorylation  was 
dramatically induced in XBP1­deficient liver, indicating the 
constitutive activation of IRE1 in the mutant mice (Fig. 3 C). 
To investigate if the hyperactivated IRE1 down­regulated 
Cyp1a2 and Cyp2e1 in XBP1­deficient liver, we suppressed 
IRE1 expression in the liver of Xbp1LKO mice using siRNA. 
Intravenous injection of lipidoid­formulated siRNA target­
ing IRE1 efficiently reduced IRE1 mRNA and protein 
levels in XBP1­deficient liver (Fig. 6). Notably, IRE1 
siRNA markedly induced hepatic Cyp1a2 and Cyp2e1 at 
both mRNA and protein levels in the liver of Xbp1LKO mice 
(Fig. 6). These data indicate that constitutively active IRE1 
decreased Cyp1a2 and Cyp2e1 mRNAs in XBP1­deficient 
liver, presumably through RIDD.
ER stress induces IRE1 mediated degradation  
of Cyp1a2 and Cyp2e1 mRNAs
Decreased expression of Cyp1a2 and Cyp2e1 mRNAs in 
tunicamycin­injected mice suggests that ER stress might also 
activate RIDD, leading to the degradation of these mRNAs 
(Fig. 5 C). To further investigate the link between the ER 
stress response and APAP metabolism, we characterized the 
phenotype of IRE1­deficient mice, which were generated 
by crossing Ern1 flox mice (Iwawaki et al., 2010) with Mx1­
cre transgenic mice. IRE1 deletion in the liver was achieved 
by poly(I:C) injection, as done previously to generate Xbp1 
mice (Lee et al., 2008). Cre­mediated deletion of exons 20 and 
21 of Ern1 caused an in­frame deletion of 64 aa (aa 844–907) 
in the ribonuclease domain of IRE1, which completely 
abolished its ribonuclease activity, thus abrogating XBP1 
mRNA  splicing  in  the  mutant  mice  (Fig.  7,  A  and  B; 
Iwawaki et al., 2010). Consistent with what we observed in 
Xbp1 mice (Lee et al., 2008), ablation of IRE1 abolished 
the induction of XBP1­dependent UPR genes such as ERdj4 
and Sec61 in the liver of tunicamycin­injected mice (Fig. 7 C). 
Expression of CHOP, which is known to be regulated pri­
marily by the PERK pathway, was not significantly altered 
in IRE1­deficient liver at the basal state or after tunicamy­
cin treatment (Fig. 7 C). Notably, however, hepatic Cyp1a2 
and Cyp2e1 mRNA levels were comparable between WT 
and Ern1 mice, in contrast to the significant reduction of 
these  mRNAs  in  XBP1­deficient  mouse  liver.  Further, 
Cyp1a2 and Cyp2e1 mRNAs were markedly decreased by 
tunicamycin  treatment  in  WT  but  not  IRE1­deficient 
mice, indicating that these mRNAs were down­regulated by 
IRE1 in response to ER stress (Fig. 7 C). Consistent with the 
normal expression of Cyp1a2 and Cyp2e1 mRNAs in Ern1 
mice, APAP­induced hepatotoxicity was comparable between 
WT and IRE1­deficient mice, as assessed by serum ALT levels 
and histological analysis (Fig. 7, D and E). However, Ern1 
mice were not more sensitive to APAP­induced hepatotoxicity 
than WT mice when challenged with a reduced dose of APAP, 
prompted us to test if the constitutively active IRE1 in­
duced the degradation of Cyp1a2 and Cyp2e1 mRNAs in 
XBP1­deficient liver.
Figure 4.  Effects of APAP on hepatic GSH levels and the forma-
tion of APAP-protein adducts in WT and Xbp1LKO mice. (A) Hepatic 
GSH levels were measured at various time points after 500 mg/kg APAP 
injection. n = 3–6 mice per group. Values represent means ± SEM.  
(B) Mice were sacrificed at indicated time points after APAP injection. 
Liver lysates of WT and Xbp1LKO mice (KO) were prepared and pooled for 
Western blot analysis using anti-APAP, anti-phospho-JNK, and total JNK 
antibodies. (C) Liver lysates from individual mice treated with APAP for  
24 h or left untreated (NT) were subjected to Western blot analysis. Note  
that the blot was exposed to x-ray film longer than in B to increase  
the sensitivity.312 IRE1 inhibits acute liver failure | Hur et al.
activation by transient overexpression suppressed the pro­
duction of these mRNAs. We co­transfected HEK293T cells 
with Cyp1a2 and Cyp2e1 plasmids, along with WT or an   
inactive mutant IRE1. Expression of Cyp1a2 and Cyp2e1 
mRNAs was markedly suppressed by the co­transfected WT, 
but not mutant IRE1 (Fig. 8 A). Similarly, co­transfected 
IRE1 reduced expression of Bloc1s1 mRNA, which has 
been identified as an IRE1 substrate for degradation in pre­
vious studies (Han et al., 2009; Hollien et al., 2009).
To directly demonstrate the cleavage of mRNAs by IRE1, 
we next generated Cyp1a2 and Cyp2e1 mRNAs by in vitro 
transcription and incubated them with recombinant IRE1 
protein. In a control experiment, IRE1 efficiently cleaved 
XBP1 mRNA, generating two fragments with the expected 
sizes, indicating that the cleavage occurred at the correct sites 
(Fig. 8 B). Notably, Cyp1a2 and Cyp2e1 mRNAs were also 
cleaved by IRE1 to smaller fragments (Fig. 8 B). As a nega­
tive control, ­actin mRNA was not cleaved by IRE1. To 
determine if IRE1 could cleave endogenously produced 
Cyp1a2 and Cyp2e1 mRNAs, we incubated recombinant 
IRE1 protein with total RNA isolated form mouse liver 
(Fig. 8 C). Northern blot analysis demonstrated that IRE1 
suggesting that basal IRE1 activity is not sufficient to con­
fer a protective effect. In conclusion, removal of IRE1 
stabilized Cyp1a2 and Cyp2e1 mRNAs and also removed 
protection  from  APAP­induced  hepatotoxicity  conferred 
by XBP1 deficiency.
Cleavage of Cyp1a2 and Cyp2e1 mRNAs by IRE1
To ascertain that Cyp1a2 and Cyp2e1 mRNAs are indeed 
degraded after cleavage by IRE1, we first tested if IRE1 
Figure 5.  Suppression of Cyp1a2 and Cyp2e1 mRNA expression by 
ER stress. (A) Mouse primary hepatocytes were infected with adenovirus 
expressing GFP or XBP1s. RNAs were isolated 24 h after viral infection for 
RT-PCR analysis. Data are mean ± SEM from quadruplicate samples.  
(B) Mice were i.p. injected with tunicamycin (1.5 mg/kg). IRE1-mediated 
XBP1 mRNA splicing and the level of XBP1s protein were measured by  
RT-PCR and Western blot, respectively. Data shown are from two indepen-
dently treated mice. Each lane represents an individual mouse.  
(C) mRNA levels of indicated genes in the liver of tunicamycin-injected mice 
measured by qRT-PCR. n = 2 mice per group.
Figure 6.  Induction of Cyp1a2 and Cyp2e1 mRNAs by siRNA 
targeting IRE1 in XBP1-deficient liver. (A) Xbp1LKO mice were 
injected with lipidoid-formulated siRNAs targeting IRE1 or lucifer-
ase. 8 d later, mice were sacrificed to isolate RNA and protein from 
the liver for qRT-PCR and Western blot analysis (B). n = 3–5 mice per 
group. **, P < 0.01.JEM Vol. 209, No. 2 
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structure prediction of individual IRE1 cleavage sites yielded 
dissimilar hairpin structures, sequence alignment of the cleavage 
sites generated a consensus secondary structure that was con­
gruent with the XBP1 hairpin, suggesting that IRE1 rec­
ognizes a common secondary structure in target mRNAs 
(Fig. 8 D). Mutation of two G residues at 1 and +3 posi­
tions in the consensus sequence abolished the cleavage of 
Cyp1a2 and Cyp2e1 mRNAs by IRE1 (Fig. 8, E–G), in­
dicating that these residues are essential for IRE1 cleav­
age. Collectively, these data demonstrate that hyperactivated 
IRE1 specifically cleaves Cyp1a2 and Cyp2e1 mRNAs in 
XBP1­deficient liver, leading to further degradation by cel­
lular ribonucleases.
APAP does not activate UPR in the liver
Recent studies demonstrated the association of ER stress 
response with a variety of liver diseases (Ji, 2008). APAP is 
known to activate ER stress response (Lorz et al., 2004; 
Nagy et al., 2007), an observation that invites the specu­
lation  that  feedback  activation  of 
IRE1 by APAP may suppress the 
production  of  NAPQI  driven  by 
Cyp1a2 and Cyp2e1. However, we 
did  not  observe  the  activation  of 
IRE1 or other UPR branches such 
as PERK and ATF6 in the liver of 
APAP­treated mice, arguing against 
a role of APAP in IRE1 activation 
(Fig. 9). Physiological and patholog­
ical conditions that activate IRE1, 
leading to the degradation of Cyp1a2 
and  Cyp2e1  mRNAs,  remained  to 
be explored.
cleaved Cyp1a2 and Cyp2e1 mRNAs at specific sites, yield­
ing smaller fragments that were largely comparable to the 
cleavage products of in vitro–transcribed mRNAs (Fig. 8,   
B and C). XBP1 mRNA was also efficiently cleaved by IRE1 
, generating a smaller fragment that was detected by a probe 
hybridizing to the 3 end of the mRNA. In contrast, ­actin 
and Cyp2c29 mRNAs, which were normally expressed in 
Xbp1­deficient liver were unaffected by recombinant IRE1 
protein (Fig. 8 C), indicating the specific cleavage of Cyp1a2 
and Cyp2e1 mRNAs by IRE1.
To determine IRE1 cleavage sites in Cyp1a2 and Cyp2e1   
mRNAs, we performed 5 rapid amplification of cDNA 
ends (RACE) PCR on in vitro–transcribed mRNAs after 
IRE1 cleavage. This procedure identified one cleavage 
site in Cyp1a2 and four sites in Cyp2e1 mRNAs (Fig. 8 D). 
DNA  sequencing  of  PCR  products  revealed  that  IRE1 
cleaves at G–C junctions within 5­CUGCAG­3 consensus 
sequences, which are conserved in XBP1 and in other RIDD 
substrate mRNAs (Oikawa et al., 2010). Although secondary 
Figure 7.  Effects of tunicamycin on gene 
expression in IRE1-deficient liver. (A) WT 
or Ern1 mice were untreated or injected i.p. 
with tunicamycin (1.5 mg/kg) 6 h before sac-
rifice. Liver lysates were subjected to Western 
blot analysis of IRE1. Ern1 mice expressed 
a mutant IRE1 lacking 64 amino acids in the 
ribonuclease domain. (B) RT-PCR was per-
formed to measure XBP1 mRNA splicing. 
XBP1s protein level was determined by Western 
blot using liver nuclear extracts. Data are 
representative of more than two independent 
experiments. (C) WT and Ern1 mice were 
injected with tunicamycin (1.5 mg/kg) and 
hepatic gene expression examined before and 
6 h after tunicamycin injection. n = 4–6 mice 
per group. **P < 0.01. (D) Mice were i.p.  
injected with 300 mg/kg APAP, and then bled 
24 h later for ALT assays. n = 6–8 mice per 
group. (E) H&E staining of liver sections.  
Images are representative of at least five inde-
pendent experiments. Mice were sacrificed  
24 h after APAP injection. Bar, 0.5 mm.314 IRE1 inhibits acute liver failure | Hur et al.
DISCUSSION
RIDD was first described in Drosophila melanogaster cells, 
where IRE1 was observed to induce the degradation of mRNAs 
encoding proteins that transit through the ER (Hollien and 
Weissman, 2006). Subsequent studies in mammalian cells 
reported that IRE1 suppressed the expression not only of   
secretory pathway cargo proteins, but also ER­resident proteins 
that handle the folding and trafficking of cargo proteins (Han 
et al., 2009). These observations raised the possibility that 
RIDD might act as a novel mechanism to alleviate ER stress 
by limiting the entry of cargo proteins into the ER. It was 
also possible that RIDD could exert opposing effects on cell fate, 
such that it might maintain homeostasis by acutely relieving ER 
stress, but promote apoptosis under conditions of prolonged, 
high level ER stress (Han et al., 2009; Hollien et al., 2009). 
However, the in vivo functions of RIDD in physiological or 
pathological situations remained to be explored. Here, we 
demonstrate that IRE1 hyperactivation in hepatocytes in 
vivo led to RIDD that resulted in protection from the stress 
of a hepatotoxic APAP metabolite. Our study reveals that the 
IRE1–XBP1 UPR signaling pathway plays a key role in 
hepatic drug metabolism, at least in part by regulating the 
stability of certain p450 mRNAs by RIDD.
Important RIDD substrates in the liver include, but may 
not be limited to, mRNAs encoding the key p450 drug­
metabolizing enzymes Cyp1a2 and Cyp2e1. Reduction of 
Cyp1a2 and Cyp2e1 mRNAs correlated with the protection 
of XBP1­deficient mice from APAP­induced hepatotoxicity, 
although it remains to be determined if the reduction of these 
mRNAs is sufficient for protection. Acute GSH depletion 
and APAP­protein adduct formation were not significantly 
altered in XBP1­deficient liver upon APAP treatment, rais­
ing the possibility that Cyp1a2­ and Cyp2e1­independent 
mechanisms might contribute to the protection of XBP1­
deficient mice from APAP­induced hepatotoxicity. There 
may well be additional RIDD substrates involved in APAP 
metabolism  required  to  confer  protection  from  APAP­ 
induced hepatotoxicity.
JNK is activated by oxidative stress, and plays a central role 
in APAP­induced hepatotoxicity (Gunawan et al., 2006; 
Henderson et al., 2007; Kaplowitz et al., 2008; Nakagawa et al., 
2008). IRE1 activates JNK under ER stress conditions (Urano 
et al., 2000). However, JNK was not induced in XBP1­
deficient liver, despite the presence of hyperactivated IRE1, 
indicating that IRE1 is not sufficient to activate JNK. 
Figure 8.  XBP1 deficiency induces feedback activation of IRE1, 
resulting in IRE1-mediated mRNA degradation of select p450 
genes. (A) 293T cells were co-transfected with CMV SPORT6-EGFP, CMV 
SPORT6-Cyp1a2, CMV SPORT6-Cyp2e1, and CMV SPORT6-Bloc1s1 to-
gether with empty, WT, or K599A mutant IRE1 plasmids. Cells were har-
vested 24 h after transfection to measure the expression levels of the 
transfected genes. mRNA levels were measured by qRT-PCR and normal-
ized to the co-transfected EGFP. Independent experiments were repeated 
at least three times and the representative result is shown. (B) Recombi-
nant IRE1 was incubated with RNA substrates generated by in vitro 
transcription using SP6 RNA polymerase. Reaction mixtures were run on 
denaturing agarose gels, which were then stained with ethidium bromide. 
Data are representative of two independent experiments. (C) In vitro 
cleavage assay was performed using liver RNA as substrate. Northern blot 
was performed to reveal mRNA cleavage.  
-Actin and Cyp2c29 mRNAs are shown as a control. Asterisks represent 
IRE1-cleaved mRNA species. (D) Nucleotide sequences around IRE1 
cleavage sites in Cyp1a2 and Cyp2e1 mRNAs. IRE1 cleaves G/C junctions 
shown in red. Matching brackets represent base pairs of the consensus 
secondary structure. (E) In vitro IRE1 cleavage assay of WT and mutant 
Cyp1a2 mRNA. (F) Predicted secondary structure of IRE1 cleavage site in 
Cyp1a2 mRNA. Arrowhead indicates the cleavage site. Two G residues 
(italicized) were changed to T to generate the mutant construct used in E. 
(G) In vitro IRE1 cleavage assay of WT and mutant Cyp2e1 mRNAs. Data 
are representative of two independent experiments.
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in the liver (Lee et al., 2008), and impaired cytokine production 
from macrophages (Martinon et al., 2010). What are the 
relative contributions of these two functions of IRE1, one 
of them XBP1­independent (RIDD) and the other dependent 
on XBP1­driven gene regulation, to the phenotypes of XBP1­
deficient mice? As we have done here, it will be critical to 
compare the phenotypes of XBP1 and IRE1 single and 
XBP1–IRE1 double­deficient mice in each organ to answer 
this question. Such studies are currently underway and should 
establish the contribution of indirect IRE1 hyperactivation 
(RIDD) induced by XBP1 deficiency versus a direct effect of 
XBP1 deficiency in vivo. We would predict, and our early 
studies support, that this balance will be different in different 
organ systems (Lee et al., 2008).
It is notable that there are both similarities and disparities 
between the phenotypes of XBP1 and IRE1 knock out 
mice. At the molecular level, Ern1 deletion abolishes the 
expression of both IRE1 and XBP1s. In contrast, Xbp1 de­
letion abolishes the expression of XBP1u and XBP1s, but 
activates IRE1 in certain organs and cell types, such as liver, 
intestinal  epithelium,    cells,  and  macrophages;  however, 
XBP1 does not activate IRE1 in neurons. Germ line dele­
tion of Ern1 or Xbp1 caused embryonic lethality in mice 
because of impaired liver development (Reimold et al., 2000; 
Zhang et al., 2005). Interestingly, the embryonic lethal phe­
notypes of these mice were reversed by expression of IRE1 
in the placenta or XBP1 in the liver (Iwawaki et al., 2009; 
Lee et al., 2005), indicating differential requirements for 
IRE1 and XBP1 in the development of these organs. XBP1­ 
and IRE1­deficient mice display abnormalities in secretory 
cells and organs, but the latter appear to have milder pheno­
types (Reimold et al., 2001; Lee et al., 2005; Iwawaki et al., 
2010). One exception to this, however, is in the B cell lineage, 
where IRE1­deficient chimeras display a halt in B cell differ­
entiation at an early stage of B cell development (Zhang et al., 
2005) in contrast to XBP1 lymphoid chimeras or B cell–specific 
Xbp1f/f;CD19+/cre mice where B cell development proceeds 
normally until the terminal stage of B cell differentiation to 
plasma cells (Reimold et al., 2000; Todd et al., 2009). It 
remains to be determined if this difference in timing and se­
verity of phenotype is caused by a contribution by RIDD or 
can be explained by different experimental settings, such as 
mouse genetic background.
Although basal IRE1 activity is low in normal mouse 
liver, it is sufficient to drive the production of measurable 
amounts of XBP1s protein. Remarkably, ablation of XBP1 
induces a striking activation of its upstream endoribonucle­
ase IRE1 in a feedback loop whose components are un­
known. It is notable that ablation of XBP1 activated IRE1, 
but not PERK or ATF6, in the liver, although a pharma­
cologic ER stress inducer, tunicamycin, simultaneously ac­
tivated all three UPR branches (Lee et al., 2008), suggesting 
that  the  signal  activating  IRE1  might  be  distinct  from 
those for other UPR branches. Identifying the molecular 
constituents of this regulatory circuit is an important goal   
of future studies.
Indeed, XBP1­deficient liver instead exhibited reduced JNK 
activation upon APAP treatment, which might contribute to 
the observed protection from APAP­induced hepatotoxicity.
In normal mouse liver, IRE1 is present mostly in an in­
active form, as indicated by minimal phosphorylation of IRE1 
and low levels of XBP1 mRNA splicing. Ablation of IRE1 
did not significantly decrease Cyp1a2 and Cyp2e1 mRNA 
levels, suggesting that the basal IRE1 activity present in 
normal mouse liver is not sufficient to cause a significant re­
duction of its substrate mRNAs. Pathophysiological condi­
tions that activate IRE1 to instigate RIDD in genetically 
intact animals remain to be identified. Interestingly, it has 
previously been shown that high­fat and high­cholesterol 
diets promote the degradation of MTP mRNA in the intes­
tine by gut­restricted IRE1 protein, suppressing chylomicron 
production (Iqbal et al., 2008). IRE1 did not cleave MTP 
mRNA, indicating the divergent substrate specificities of 
IRE1 and IRE1 (Iqbal et al., 2008). Various insults to   
hepatocytes, such as fat accumulation, viral infection, inflam­
mation, hyperhomocysteinemia, and oxidative stress, have 
been implicated in the ER stress response in the liver (Ji, 2008), 
and it would be interesting to see if RIDD is instigated under 
these conditions.
Hyperactivation of IRE1 either through elimination of its 
substrate XBP1 or through pharmacologically induced ER 
stress can instigate RIDD. The fact that XBP1 deficiency 
causes hyperactivation of IRE1 which can induce the deg­
radation of certain mRNAs raises an interesting question. 
Ablation of XBP1 causes multiple abnormalities in many 
organ systems in mice, which include the deficiency of pro­
fessional secretory cells (Reimold et al., 2001; Lee et al., 
2005; Kaser et al., 2008; Huh et al., 2010), defective insulin 
secretion from  cells (Lee et al., 2011), decreased lipogenesis 
Figure 9.  APAP does not induce the UPR in liver. (A) Mice were 
injected i.p. with 500 mg/kg APAP after a 16-h fast, and then sacrificed at 
indicated time points. XBP1 mRNA splicing in the liver was measured by 
RT-PCR as a marker of IRE1 activity. (B) Western blot analysis of whole-
liver lysates. Liver lysate of a tunicamycin-treated mouse was included as 
a positive control. Each lane represents an individual mouse.316 IRE1 inhibits acute liver failure | Hur et al.
domain of human IRE1 (28, 14, 7, and 3.5 ng) was incubated with 1 µg 
of RNA generated by in vitro transcription using SP6 or T7 polymerase 
(Invitrogen) and specific MGC cDNA clones in pCMV­SPORT6 vector 
(Open Biosystems), or 3 µg of total liver RNA for 30 min at 37°C. IRE1­
mediated cleavage of in vitro–transcribed RNA was revealed by ethidium 
bromide staining of the agarose gel after electrophoresis. Liver RNA treated 
with IRE1 was resolved on denaturing agarose gels and subjected to Northern 
blot analysis. Radiolabeled probes were prepared using Rediprime II ran­
dom prime labeling system (GE Healthcare). Templates for radiolabeled 
probes were generated by PCR amplification of the fragments of Cyp1a2 
(+1 to +1093, BC064827), Cyp2c29 (+9 to +412, BC019908), and Cyp2e1 
(+1 to +512, BC013451) cDNAs.
Identification of IRE1 cleavage sites in Cyp1a2 and Cyp2e1 mRNAs. 
Cyp1a2 and Cyp2e1 mRNAs produced by in vitro transcription were incubated 
with recombinant IRE1. IRE1­cleaved RNAs were treated with T4 poly­
nucleotide kinase, and then ligated with 5­RACE adapter (5­GCUGAUG­
GCGAUGAAUGAACACUGCGUUUGCUGGCUUUGAUGAAA­3;   
Invitrogen) using T4 RNA ligase (New England BioLabs). After a purification 
step using RNeasy MinElute Cleanup kit (QIAGEN), ligated RNAs were sub­
jected to cDNA synthesis followed by PCR amplification using RACEouter 
primer (5­GCTGATGGCGATGAATGAACACTG­3) and various reverse 
primers that anneal to Cyp1a2 and Cyp2e1 mRNAs with 300–400­bps inter­
vals. PCR products were subjected to DNA sequencing.
Online supplemental material. Table S1 shows the expression of genes   
related to drug metabolism in XBP1­deficient liver. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20111298/DC1.
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